Cambridge scientists elected as Members of the European Molecular Biology Organisation
Dr David Adams, Senior Group Leader - Cambridge Cancer Centre; Department of Medicine; Wellcome Sanger Institute“I'm honoured to be recognised by EMBO, which not only validates the hard work and dedication of my team but also opens new doors for collaboration and innovation.
"I am excited about the opportunities it brings to advance our research and contribute to the global scientific community.”Adams' research aims to understand why specific types of cancer are more common in some families, and how changes we inherit from our parents may contribute.
He is also interested in understanding how to generate more specific cancer treatments, particularly in the context of pre-malignant conditions.
Dr David Adams, Senior Group Leader - Cambridge Cancer Centre; Department of Medicine; Wellcome Sanger Institute
“I'm honoured to be recognised by EMBO, which not only validates the hard work and dedication of my team but also opens new doors for collaboration and innovation.
"I am excited about the opportunities it brings to advance our research and contribute to the global scientific community.”
Adams' research aims to understand why specific types of cancer are more common in some families, and how changes we inherit from our parents may contribute. He is also interested in understanding how to generate more specific cancer treatments, particularly in the context of pre-malignant conditions.
